Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation

Melissa M. Rosas, Michal J. Sobieszczyk, Whittney Warren, Phillip Mason, Robert J. Walter, Joseph E. Marcus

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed recurrent fungal infections.

Original languageEnglish (US)
Article numberofac374
JournalOpen Forum Infectious Diseases
Issue number8
StatePublished - Aug 1 2022
Externally publishedYes


  • COVID-19
  • extracorporeal membrane oxygenation
  • fungemia

ASJC Scopus subject areas

  • Infectious Diseases
  • Oncology


Dive into the research topics of 'Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation'. Together they form a unique fingerprint.

Cite this